InMed Pharmaceuticals Statistics Share Statistics InMed Pharmaceuticals has 2M
shares outstanding. The number of shares has increased by 176.49%
in one year.
Shares Outstanding 2M Shares Change (YoY) 176.49% Shares Change (QoQ) 65.86% Owned by Institutions (%) 0% Shares Floating 1.99M Failed to Deliver (FTD) Shares 384 FTD / Avg. Volume 0.41%
Short Selling Information The latest short interest is 17.96K, so 0.9% of the outstanding
shares have been sold short.
Short Interest 17.96K Short % of Shares Out 0.9% Short % of Float 0.9% Short Ratio (days to cover) 1
Valuation Ratios PE Ratio 0 Forward PE n/a PS Ratio 0 Forward PS 0 PB Ratio 0 P/FCF Ratio -0.41 PEG Ratio 0
Financial Ratio History Enterprise Valuation Currently the Enterprise Value (EV) is not available for InMed Pharmaceuticals.
EV / Sales n/a EV / EBITDA n/a EV / EBIT n/a EV / FCF n/a
Financial Position The company has a current ratio of 6.99,
with a Debt / Equity ratio of 0.02.
Current Ratio 6.99 Quick Ratio 6.47 Debt / Equity 0.02 Debt / EBITDA -0.1 Debt / FCF -0.13 Interest Coverage 0
Financial Efficiency Return on Equity is n/a and Return on Invested Capital is n/a.
Return on Equity n/a Return on Assets n/a Return on Invested Capital n/a Revenue Per Employee $380.11K Profits Per Employee $-627.71K Employee Count 13 Asset Turnover 0.32 Inventory Turnover 3.37
Taxes Income Tax n/a Effective Tax Rate 0%
Stock Price Statistics The stock price has increased by -48.28% in the
last 52 weeks. The beta is 0.41, so InMed Pharmaceuticals's
price volatility has been higher than the market average.
Beta 0.41 52-Week Price Change -48.28% 50-Day Moving Average 2.28 200-Day Moving Average 2.94 Relative Strength Index (RSI) 51.2 Average Volume (20 Days) 92,595
Income Statement In the last 12 months, InMed Pharmaceuticals had revenue of 4.94M
and earned -8.16M
in profits. Earnings per share was -8.
Revenue 4.94M Gross Profit 1.71M Operating Income -7.7M Net Income -8.16M EBITDA -7.7M EBIT -7.92M Earnings Per Share (EPS) -8
Full Income Statement Balance Sheet The company has 11.12M in cash and 744.37K in
debt, giving a net cash position of 10.38M.
Cash & Cash Equivalents 11.12M Total Debt 744.37K Net Cash 10.38M Retained Earnings -117.73M Total Assets 15.58B Working Capital 11.03B
Full Balance Sheet Cash Flow In the last 12 months, operating cash flow was -5.7M
and capital expenditures 0, giving a free cash flow of -5.7M.
Operating Cash Flow -5.7M Capital Expenditures n/a Free Cash Flow -5.7M FCF Per Share -7.96
Full Cash Flow Statement Margins Gross margin is 34.53%, with operating and profit margins of -155.89% and -165.14%.
Gross Margin 34.53% Operating Margin -155.89% Pretax Margin -165.14% Profit Margin -165.14% EBITDA Margin -151.59% EBIT Margin -155.89% FCF Margin -115.37%
Dividends & Yields INM does not appear to pay any dividends at this time.
Dividend Per Share n/a Dividend Yield n/a Dividend Growth (YoY) n/a Payout Ratio n/a Earnings Yield n/a FCF Yield n/a
Dividend Details Analyst Forecast Currently there are no analyst rating for INM.
Price Target n/a Price Target Difference n/a Analyst Consensus n/a Analyst Count n/a
Stock Forecasts Fair Value There are several formulas that can be used to estimate the
intrinsic value of a stock.
Lynch Fair Value n/a Lynch Upside n/a Graham Number n/a Graham Upside n/a
Stock Splits The last stock split was on Nov 14, 2024. It was a
backward
split with a ratio of 1:20.
Last Split Date Nov 14, 2024 Split Type backward Split Ratio 1:20
Scores Altman Z-Score -11 Piotroski F-Score 2
